Viewing Study NCT04452994


Ignite Creation Date: 2025-12-25 @ 1:33 AM
Ignite Modification Date: 2025-12-26 @ 4:49 AM
Study NCT ID: NCT04452994
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2025-06-13
First Post: 2020-06-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Individual Patient Investigational New Drug (IND) Expanded Access Program of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy for Participant With Multiple Myeloma
Sponsor: Janssen Research & Development, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module